Clinical Trials Directory

Trials / Sponsors / Atossa Therapeutics, Inc.

Atossa Therapeutics, Inc.

Industry · 8 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Recruiting(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Breast Neoplasms, Invasive Breast Cancer, Estrogen-receptor-positive Breast Cancer
Phase 22023-02-14
Active Not RecruitingEffect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast Density
Breast Density
Phase 22021-12-21
CompletedAT-301 Nasal Spray in Healthy Adults
Healthy
Phase 12020-08-07
CompletedTopical Endoxifen in Women
Mammographic Breast Density
Phase 22018-04-09
TerminatedA Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant
Female Breast Carcinoma, Female Ductal Carcinoma In Situ
Phase 22016-03-01
WithdrawnA Trial of the ForeCYTE Breast Aspirator for Cytological Testing of Nipple Aspirate Fluid in Women 30-55 Years
Breast Cancer, Preneoplastic Conditions, BRCA
Phase 32015-09-01
CompletedForeCYTE Breast Aspirator for Sample Collection and Cytological Testing of Nipple Aspirate Fluid
Breast Neoplasms
—2014-08-01
CompletedThe Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and L
Breast Cancer, Preneoplastic Conditions, Ductal Carcinoma in Situ
—2011-07-01